NCT04379154View on ClinicalTrials.gov

Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19)

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

April 14, 2020

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2021

Conditions
COVID-19
Interventions
DEVICE

Volatile Organic Compounds analysis

Volatile Organic Compounds analysis in exhaled air by electronic noses

Trial Locations (1)

Unknown

Hôpital Foch, Suresnes

All Listed Sponsors
lead

Hopital Foch

OTHER

NCT04379154 - Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19) | Biotech Hunter | Biotech Hunter